Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

6.84 (USD) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 125.575108.84799.752128.10159.05547.02751.84754.912112.394103.664138.305346.071367.034357.06168.43641.699-5.995
Short Term Investments 116.611153.35893.14104.312119.422156.039179.887207.914159.755190.481178.8580000011.99
Cash and Short Term Investments 242.186262.205192.892232.413178.477203.066231.734262.826272.149294.145317.163346.071367.034357.06168.43641.6995.995
Net Receivables 0.5959.8420.6010.5050.2941.1542.177.65617.55700000000
Inventory 0000000.960.96000000000
Other Current Assets 8.4265.8495.5433.2944.143.8846.6525.4045.5295.86.4065.196.972.4183.1921.7920
Total Current Assets 251.207277.896199.036236.212182.911208.104240.556275.886295.235297.045320.366348.666370.519358.289171.70743.5915.995
Non-Current Assets:
Property, Plant & Equipment, Net 58.80661.14362.45862.61164.465.69463.861.90757.91862.30720.30612.32511.8018.9237.7324.6230
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 04.8664.8634.584.5224.5274.3214.3184.3025.325.3335.3381.7291.7291.16400
Tax Assets 00000000000000000
Other Non-Current Assets 5.0670.2090.3890.3520.270.2910.3510.2780.1480.384000001.164-5.995
Total Non-Current Assets 63.87366.21867.7167.54369.19270.51268.47266.50362.36868.01125.63917.66313.5310.6528.8965.787-5.995
Total Assets 315.08344.114266.746303.755252.103278.616309.028342.389357.603365.056346.005366.329384.049368.941180.60349.3780
Liabilities & Equity:
Current Liabilities:
Account Payables 3.9786.4736.82811.1525.55.3087.3827.8629.7534.2944.5116.5583.537.4637.3267.0660
Short Term Debt 3.6466.9423.3456.3245.7625.3345.786.2546.135.3243.048000000
Tax Payables 00000000000000000
Deferred Revenue 18.91819.64520.40717.67811.328.65800000000000
Other Current Liabilities 15.0999.28810.71311.43811.3478.4477.35311.4535.9075.1554.93110.089.2133.3281.76522.2090
Total Current Liabilities 41.64142.34841.29346.59222.60919.08920.51525.56921.7914.77312.4916.63812.74310.7919.09129.2750
Non-Current Liabilities:
Long Term Debt 40.05240.88541.83742.87743.51744.36843.27543.87442.59346.0955.457000231.17200
Deferred Revenue Non-Current 033.59628.52932.3231.4531.5051.51202.1282.1382.18302.0011.4720.95600
Deferred Tax Liabilities Non-Current 0000-1.453-1.505-1.5120-2.128-2.138-2.183000-232.12800
Other Non-Current Liabilities 27.932.6142.5682.7131.4531.5051.5121.5332.1282.1382.1832.1762.0011.472068.8310
Total Non-Current Liabilities 67.98277.09572.93477.91344.9745.87344.78745.40744.72148.2337.642.1762.0011.472232.12868.8310
Total Liabilities 109.623119.443114.227124.50567.57964.96265.30270.97666.51163.00620.1318.81414.74412.263241.21998.1060
Equity:
Preferred Stock 000000000000384.049368.941231.17267.76418.95
Common Stock 0.0060.0060.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0040.0010.0010
Retained Earnings -452.025-428.166-397.856-365.888-332.636-297.752-262.574-230.536-199.754-172.436-145.967-122.035-98.595-78.758-60.353-48.0770
Accumulated Other Comprehensive Income/Loss -2.322-2.67-2.693-2.724-1.455-1.64-1.393-1.752-2.602-2.458-2.133-2.021-1.95-1.415-0.92-1.056-12.148
Other Total Stockholders Equity 659.798655.501553.063547.857518.61513.041507.688503.696493.443476.939473.97471.566469.845436.8470.656-67.7640
Total Shareholders Equity 205.457224.671152.519179.25184.524213.654243.726271.413291.092302.05325.875347.515369.305356.678-60.616-48.7286.802
Total Equity 205.457224.671152.519179.25184.524213.654243.726271.413291.092302.05325.875347.515369.305356.678-60.616-48.7286.802
Total Liabilities & Shareholders Equity 315.08344.114266.746303.755252.103278.616309.028342.389357.603365.056346.005366.329384.049368.941180.60349.3786.802